Clinicopathologic analysis of spindle cell/sclerosing rhabdomyosarcoma.

  title={Clinicopathologic analysis of spindle cell/sclerosing rhabdomyosarcoma.},
  author={Naoko Yasui and Akihiko Yoshida and Hiroshi Kawamoto and Kan Yonemori and Ako Hosono and Akira Kawai},
  journal={Pediatric blood & cancer},
  volume={62 6},
BACKGROUND Clinical characteristics and optimal treatment strategies for spindle cell/sclerosing rhabdomyosarcoma (ssRMS) have not been well established because of its rarity. PROCEDURE Retrospective re-evaluation of sarcoma specimens (1997-2014) identified 16 ssRMSs (median age 20 years, range 7-39 years). Clinicopathological features, clinical course, and outcome were analyzed. RESULTS Primary disease sites were the head and neck (10 cases) and other regions (6 cases). Nine cases were at… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 19 references

PCW,Mertens F.WHO classification of tumours of soft tissue and bone

CDM Fletcher, JA Bridge, Hogendoorn
View 6 Excerpts
Highly Influenced

Rhabdomyosarcoma. In:Weiss SW,Goldblum JR, editors. Enzinger andWeiss’s soft tissue tumors

SW Weiss, Goldblum
Mosby; • 2008
View 1 Excerpt

Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society • 2005
View 2 Excerpts

Similar Papers

Loading similar papers…